EsoGuard Testing
EsoGuard Testing
Central Ohio Reflux Surgery offers EsoGuard Testing for early detection of esophageal cancer. This non-invasive test detects abnormal cells in the esophagus to aid in early treatment and prevention. Esophageal cancer is one of the fastest-growing cancers in the United States, and early detection is crucial for successful treatment. Our experienced healthcare professionals provide personalized testing services and compassionate care to ensure our patients receive the best possible outcomes. Contact us today to learn more about EsoGuard Testing.
Contact Us
What Is EsoGuard Testing?
EsoGuard Testing refers to a DNA test designed to detect abnormal esophageal cells, including Barrett's Esophagus, precancerous cells with dysplasia, and cancer. It is a laboratory-developed test that analyzes 31 methylated biomarkers to accurately identify these conditions with high specificity and sensitivity. EsoGuard Testing utilizes next-generation sequencing technology and typically takes five minutes or less to complete. This non-invasive test offers a simple and efficient screening tool for individuals with a history of mild heartburn, GERD, or other risk factors for esophageal cancer. It provides an opportunity for early detection and diagnosis, allowing for timely intervention and treatment.
Who Should Get EsoGuard Testing?
- Patients with a history of chronic heartburn, GERD, and Barrett's Esophagus are at risk for esophageal cancer.
- Early detection is crucial for improving treatment outcomes and preventing esophageal cancer development.
- People with high risk for obesity, smoking, or heavy alcohol consumption.
- Individuals with a diet high in processed meats and low in fruits and vegetables.
- Consult with healthcare professionals to determine if EsoGuard Testing is appropriate for you.
Early Detection for Esophageal Cancer
EsoGuard Testing provides an efficient and non-invasive method for the early detection of esophageal cancer. This testing service detects abnormal esophageal cells, such as those in Barrett's Esophagus, dysplasia, and cancer, using a DNA test that analyses 31 methylated biomarkers. The procedure, which typically takes less than five minutes, leverages next-generation sequencing technology for high specificity and sensitivity. Particularly recommended for individuals with a history of mild heartburn, GERD, or other risk factors for esophageal cancer, EsoGuard Testing aids in timely intervention and treatment. Our healthcare providers offer personalized services and compassionate care to ensure the best possible outcomes for our patients. Contact us today to take a proactive step toward your health.